Related Experiment Video
Updated: May 29, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Optimizing revascularization strategies in coronary artery disease for optimal benefit to patients
F Mangiacapra1, B De Bruyne, W Wijns
1Cardiovascular Center, OLV Hospital and Cardiovascular Research Center, Aalst, Belgium.
Insights
Optimizing revascularization strategies for coronary artery disease (CAD) is crucial. Recent trials and European guidelines inform decisions between coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI).
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Interventional Cardiology
Background:
- Coronary artery disease (CAD) management involves revascularization.
- Coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) are established therapeutic options.
- Technological advancements have significantly improved CABG and PCI procedures.
Purpose of the Study:
- To focus on optimizing decision-making in revascularization strategies for CAD.
- To review recent large clinical trials impacting revascularization choices.
- To align with current guidelines from the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS).
Main Methods:
- Analysis of recent large-scale clinical trials.
- Review of European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS) guidelines.
- Focus on comparative effectiveness of revascularization techniques.
Main Results:
- Substantial technological progress in CABG and PCI.
- Revascularization remains a key treatment for CAD.
- Emerging data and guidelines refine treatment selection.
Conclusions:
- Optimized decision-making is essential for CAD revascularization.
- Evidence from recent trials and guidelines supports informed choices between CABG and PCI.
- The integration of new data enhances patient care strategies.
Abstract:
Coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) have undergone substantial technological advances, and revascularization is an established therapeutic option in the treatment of coronary artery disease (CAD). Here we focus on optimization of decision making in revascularization strategies, as is being addressed in recent large clinical trials and the guidelines issued by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management
Peripheral Artery Disease III: Interprofessional Care
Atherosclerosis III: Management
Angina V: Nursing Management